Bronwen Shaw


Bronwen Shaw, MD, PhD is the Chief Scientific Director CIBMTR MCW and Professor of Medicine, seeing transplant and cellular therapy patients. She has a long standing interest in determining factors which help to select the best unrelated donor for an individual patient. She also has an interest in health-related quality of life and survivorship issues in patients who undergo hematopoietic cell transplantation. She is also interested in the ability of patient reported outcome (PRO) collection to predict patient experience and clinical outcomes.